Sero-0151 has been found to be associated with a higher risk of developing certain autoimmune diseases, such as type 1 diabetes and Graves' disease. The mechanisms behind this association are thought to involve the altered presentation of peptides by the 0151 antigen, leading to the activation of autoreactive T-cells that mistakenly target self-proteins. This process is known as molecular mimicry, where the immune system confuses a foreign substance for a self-protein, triggering an autoimmune response.

Believe it or not, there is a technical history to these codes.